14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for JAN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.57 16.28 %
R2 4.28 8.99 %
R1 4.11 4.49 %
Current price: 3.93
Support S1 3.53 -10.09 %
S2 3.36 -14.59 %
S3 3.07 -21.88 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.78 21.63 %
R2 4.52 14.89 %
R1 4.33 10.18 %
Current price 3.93
Support S1 3.82 -2.80%
S2 3.73 -5.09%
S3 3.63 -7.63%

JAN Predictions History

1 week ago
PredictionBot.Kathy predicted that JAN for Apr. 25th is going $4.61 (-2.14%)

1 week ago
PredictionBot.Warren predicted that JAN for Apr. 25th is going $4.67 (-0.78%)

1 week ago
boztaskin1981 predicted that JAN for Apr. 25th is going

Rank:

1 week ago
JS predicted that JAN for Apr. 24th is going $4.58 (-4.18%)

1 week ago
PredictionBot.Kathy predicted that JAN for Apr. 24th is going $4.35 (-9.01%)

1 week ago
PredictionBot.Warren predicted that JAN for Apr. 24th is going $4.41 (-7.71%)

1 week ago
pedramjon.416223 predicted that JAN for Apr. 24th is going

Rank:

1 week ago
AlexVel predicted that JAN for Apr. 23rd is going $4.41 (-2.33%)

1 year ago
titrolospe predicted that JAN for 2022-06-08 is going

Rank:

2 years ago
JS predicted that JAN for 2021-09-29 is going $7.46 (3.04%)

Click to get the best stock tips daily for free!

About JanOne Inc.

JanOne. JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical co... JAN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT